EUVIMEDEUVIMED entdecken
Fallbericht

Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab

Anthony Ocon, Eduardo Avalos Sugastti, Nananamibia Duffy

BMJ Case Reports · 2024

DOI: 10.1136/bcr-2023-258487 ↗

Kurz gefasst

Fallbericht in der Zeitschrift BMJ Case Reports, 2024. Verfasst von Anthony Ocon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, Rochester Regional Health, Rochester, New York, USA anthony.ocon@rochesterregional.org. Hauptthemen laut MEDLINE: Lupus Erythematosus, Discoid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic discoid lupus erythematosus is a rare variant of chronic cutaneous lupus erythematosus and is often challenging to treat. A male in his early 60s presented with diffuse erythematous, crusty, pruritic plaques on his upper and lower extremities, face, upper back, dorsal aspect of the hands and chest. He also described prolonged morning stiffness, swelling of his fingers and wrists, oral sores and Raynaud’s phenomenon. He was positive for antinuclear antibody and anti-SSA antibody and had low C3 and C4 proteins. The skin biopsy was consistent with hypertrophic discoid lupus erythematosus. He was diagnosed with systemic lupus erythematosus. Skin lesions were refractory to treatment with topical corticosteroids, topical acitretin, hydroxychloroquine, azathioprine or mycophenolate. Anifrolumab infusions were initiated with a near-complete resolution of cutaneous symptoms within 3 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, DiscoidHumansMaleMiddle AgedTreatment OutcomeAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal

Stichwörter der Autor:innen

connective tissue diseasedermatologyrheumatologysystemic lupus erythematosus

Substanzen

Antibodies, Monoclonal, HumanizedAntibodies, Monoclonal

Autor:innen und Institutionen

  • Rheumatology, Rochester Regional Health, Rochester, New York, USA anthony.ocon@rochesterregional.org.
  • Rheumatology, URMC, Rochester, New York, USA.
  • Internal Medicine, Rochester Regional Health, Rochester, New York, USA.
  • Dermatology, Rochester Regional Health, Rochester, New York, USA.

Zitieren

APA

Ocon, A., Avalos Sugastti, E., & Duffy, N. (2024). Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab. BMJ Case Reports. https://doi.org/10.1136/bcr-2023-258487

Vancouver

Ocon A, Avalos Sugastti E, Duffy N. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab. BMJ Case Reports. 2024. doi:10.1136/bcr-2023-258487

BibTeX
@article{Ocon2024,
  author = {Ocon, Anthony and Avalos Sugastti, Eduardo and Duffy, Nananamibia},
  title = {Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab},
  journal = {BMJ Case Reports},
  year = {2024},
  doi = {10.1136/bcr-2023-258487}
}
Kostenlos starten →